PAH genotypes and their impact on sapropterin responsiveness in Thai patients with phenylalanine hydroxylase deficiency

Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are inherited metabolic disorders caused by phenylalanine hydroxylase (PAH) deficiency, leading to phenylalanine (Phe) accumulation and subsequent neurological impairment. Sapropterin therapy effectively reduces Phe levels in responsive patients, yet its efficacy among Thai patients with PAH deficiency remains unclear. A cohort study incorporating prospective and retrospective data enrolled 13 Thai patients with PAH deficiency from three rare disease centers. Participants underwent a 48-hour sapropterin loading test (20 mg/kg/day) with serial Phe measurements. Responsiveness was defined as a > 30% reduction in Phe levels. Genotype and Allelic Phenotype Value (APV) analyses were performed. In the five responsive patients who continued long-term sapropterin therapy, natural protein intake and psychometric outcomes were assessed longitudinally over six months. Sapropterin responsiveness was observed in 61.5% of patients, higher than previously reported. No patients with classic PKU responded, compared with 80% of those with mild PKU and 100% with mild HPA. Concordance between APV-predicted and observed phenotypes was 77.8%. Thai-specific PAH variants, p.(Arg169Leu), p.(Asp229GlufsTer54), and p.(Tyr317Asn), and a novel variant, p.(Gln226Glu), were identified. The 48-hour protocol improved detection of responsiveness compared with shorter durations. Among the five responsive patients who continued sapropterin treatment, natural protein tolerance increased, whereas no clear change in short-term psychometric outcomes was observed. This study represents the first cohort evaluating sapropterin responsiveness in Thai patients with PAH deficiency. Although limited by the small sample size, our findings suggest that sapropterin responsiveness may be relatively common among patients with milder phenotypes and provide preliminary data on genotype–phenotype correlations in the Thai population.

Authors

Institutions

Publication Details

Journal
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics
Published
2026-09-28
DOI
https://doi.org/10.1186/s13052-026-02343-1
Primary Topic
Metabolism and Genetic Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

PAH genotypes and their impact on sapropterin responsiveness in Thai patients with phenylalanine hydroxylase deficiency

Sudarat Sirisakpanit, Lukana Ngiwsara, N. Densupsoontorn, Nithiwat Vatanavicharn et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics
Metabolism and Genetic Disorders
article

PAH genotypes and their impact on sapropterin responsiveness in Thai patients with phenylalanine hydroxylase deficiency

Sudarat Sirisakpanit, Lukana Ngiwsara, N. Densupsoontorn, Nithiwat Vatanavicharn, Duangrurdee Wattanasirichaigoon, Khunton Wichajarn, Thipwimol Tim‐Aroon, Hathaichanok Rukprayoon, Napat Sittanomai, Somporn Liammongkolkul, Dhachdanai Dhachpramuk, Souwaluck Ratanamalaya
article en

Abstract

Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are inherited metabolic disorders caused by phenylalanine hydroxylase (PAH) deficiency, leading to phenylalanine (Phe) accumulation and subsequent neurological impairment. Sapropterin therapy effectively reduces Phe levels in responsive patients, yet its efficacy among Thai patients with PAH deficiency remains unclear. A cohort study incorporating prospective and retrospective data enrolled 13 Thai patients with PAH deficiency from three rare disease centers. Participants underwent a 48-hour sapropterin loading test (20 mg/kg/day) with serial Phe measurements. Responsiveness was defined as a > 30% reduction in Phe levels. Genotype and Allelic Phenotype Value (APV) analyses were performed. In the five responsive patients who continued long-term sapropterin therapy, natural protein intake and psychometric outcomes were assessed longitudinally over six months. Sapropterin responsiveness was observed in 61.5% of patients, higher than previously reported. No patients with classic PKU responded, compared with 80% of those with mild PKU and 100% with mild HPA. Concordance between APV-predicted and observed phenotypes was 77.8%. Thai-specific PAH variants, p.(Arg169Leu), p.(Asp229GlufsTer54), and p.(Tyr317Asn), and a novel variant, p.(Gln226Glu), were identified. The 48-hour protocol improved detection of responsiveness compared with shorter durations. Among the five responsive patients who continued sapropterin treatment, natural protein tolerance increased, whereas no clear change in short-term psychometric outcomes was observed. This study represents the first cohort evaluating sapropterin responsiveness in Thai patients with PAH deficiency. Although limited by the small sample size, our findings suggest that sapropterin responsiveness may be relatively common among patients with milder phenotypes and provide preliminary data on genotype–phenotype correlations in the Thai population.

˜The œItalian Journal of Pediatrics/Italian journal of pediatrics
Siriraj Hospital (TH), Khon Kaen University (TH), Mahidol University (TH), Chulabhorn Research Institute (TH), Ramathibodi Hospital (TH)
Openalex Percentile: Top 16%
Metabolism and Genetic Disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.